Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Biopharma Inc (NASDAQ:TBPH)

36.73
BATS BZX Real-Time Price
As of 1:51pm ET
 +0.95 / +2.66%
Today’s Change
10.56
Today|||52-Week Range
36.73
+124.10%
Year-to-Date
No recent news for Theravance Biopharma Inc.

Today’s Trading

Previous close35.78
Today’s open35.59
Day’s range35.50 - 36.73
Volume4,287
Average volume (3 months)258,265
Market cap$1.7B
Dividend yield--
Data as of 1:51pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+28.42%
Earnings growth (this year)+24.63%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)+260.42%
P/E ratioNM
Price/Sales13.29
Price/Book5.59

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-0.10-0.22%
ITCIIntra-Cellular Thera...+0.51+1.25%
ALDRAlder Biopharmaceuti...+0.88+2.69%
IPXLImpax Laboratories I...+0.42+1.65%
Data as of 1:51pm ET, 09/27/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.93
Annual revenue (last year)$42.1M
Annual profit (last year)-$182.2M
Net profit margin-432.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Senior VP &
Global Head-Acute Care Business
Frank C. Pasqualone
Corporate headquarters
George Town, George Town

Forecasts

Search for Jobs